{
    "id": "dbpedia_1851_0",
    "rank": 90,
    "data": {
        "url": "https://synapse.patsnap.com/organization/08442d3f137cc088f7299c642e1431f1",
        "read_more_link": "",
        "language": "en",
        "title": "Vigil Neuroscience, Inc.",
        "top_image": "https://synapse-tour.cdn.patsnap.com/synapse/open_resource/org_logo/prod/COMPANY/MASTER/LOGO/0844/2d3f/137c/c088/f729/9c64/2e14/31f1/3e290df864401e33_48w.webp",
        "meta_img": "https://synapse-tour.cdn.patsnap.com/synapse/open_resource/org_logo/prod/COMPANY/MASTER/LOGO/0844/2d3f/137c/c088/f729/9c64/2e14/31f1/3e290df864401e33_48w.webp",
        "images": [
            "https://synapse-tour.cdn.patsnap.com/synapse/open_resource/org_logo/prod/COMPANY/MASTER/LOGO/0844/2d3f/137c/c088/f729/9c64/2e14/31f1/3e290df864401e33_48w.webp",
            "https://synapse-tour.cdn.patsnap.com/synapse/open_resource/org_logo/prod/COMPANY/MASTER/LOGO/0844/2d3f/137c/c088/f729/9c64/2e14/31f1/3e290df864401e33_48w.webp",
            "https://synapse-tour.cdn.patsnap.com/synapse/open_resource/org_logo/prod/COMPANY/MASTER/LOGO/11ef/8a9e/8bf5/ca80/213a/1183/511c/ded3/577289a9efbc495d_48w.webp",
            "https://synapse-tour.cdn.patsnap.com/synapse/open_resource/org_logo/prod/COMPANY/MASTER/LOGO/0844/2d3f/137c/c088/f729/9c64/2e14/31f1/3e290df864401e33_48w.webp",
            "https://synapse-tour.cdn.patsnap.com/synapse/open_resource/org_logo/prod/COMPANY/MASTER/LOGO/0844/2d3f/137c/c088/f729/9c64/2e14/31f1/3e290df864401e33_48w.webp",
            "https://synapse-tour.cdn.patsnap.com/synapse/open_resource/org_logo/prod/COMPANY/MASTER/LOGO/0844/2d3f/137c/c088/f729/9c64/2e14/31f1/3e290df864401e33_48w.webp",
            "https://synapse-tour.cdn.patsnap.com/synapse/open_resource/org_logo/prod/COMPANY/MASTER/LOGO/0844/2d3f/137c/c088/f729/9c64/2e14/31f1/3e290df864401e33_48w.webp",
            "https://synapse-tour.cdn.patsnap.com/synapse/open_resource/org_logo/prod/COMPANY/MASTER/LOGO/0844/2d3f/137c/c088/f729/9c64/2e14/31f1/3e290df864401e33_48w.webp",
            "https://synapse-tour.cdn.patsnap.com/synapse/open_resource/org_logo/prod/COMPANY/MASTER/LOGO/0844/2d3f/137c/c088/f729/9c64/2e14/31f1/3e290df864401e33_48w.webp",
            "https://synapse-tour.cdn.patsnap.com/synapse/open_resource/org_logo/prod/COMPANY/MASTER/LOGO/0844/2d3f/137c/c088/f729/9c64/2e14/31f1/3e290df864401e33_48w.webp",
            "https://synapse-static.patsnap.com/ssr/ac0dc40f/_nuxt/en-corp-tree.1891d746.png",
            "https://synapse-static.patsnap.com/ssr/ac0dc40f/_nuxt/en-drug-deal.78729d7c.png",
            "https://synapse-static.patsnap.com/ssr/ac0dc40f/_nuxt/en-translational-medicine.b428d8c3.png",
            "https://synapse-static.patsnap.com/ssr/ac0dc40f/_nuxt/en-profit.e8449358.png",
            "https://synapse-static.patsnap.com/ssr/ac0dc40f/_nuxt/en-funding.a5fdebb5.png",
            "https://synapse-static.patsnap.com/ssr/ac0dc40f/_nuxt/en-investment.6a82dd7e.png",
            "https://synapse-static.patsnap.com/ssr/ac0dc40f/_nuxt/en-financing.27c56893.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "Vigil Neuroscience",
            "Inc.",
            "VGL-101",
            "VG-3927",
            "Small Molecule TREM2 Agonist (Vigil Neuroscience)",
            "NASDAQ: VIGL"
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "Explore Vigil Neuroscience, Inc. with its drug pipeline, therapeutic area, technology platform, 5 clinical trials, 19 news, and 14 literature, Disease Domain:Nervous System Diseases, Endocrinology and Metabolic Disease, Technology Platform:Monoclonal antibody, Molecular glue, Small molecule drug, Drug:VGL-101, VG-3927, Small Molecule TREM2 Agonist (Vigil Neuroscience).",
        "meta_lang": "en",
        "meta_favicon": "/favicon.ico",
        "meta_site_name": "",
        "canonical_link": "https://synapse.patsnap.com/organization/08442d3f137cc088f7299c642e1431f1",
        "text": "Introduction\n\nVigil Neuroscience, Inc. is a corporation that specializes in offering biotechnology research services. It dedicates its work towards enhancing the lives of those who are affected by neurodegenerative diseases, including patients, caregivers, and family members, by contributing to the creation of therapeutics that could modify the disease and revive the vigilance of microglia. Established on June 22, 2020, the company operates from its main office located in Watertown, MA."
    }
}